#66 Seasoned Biotech Executive talks T-Cell Therapy and Running a Business in 2023!

On this episode of BioTech IQ, Ammon interviews Paul Lammers the CEO of Triumvira about developing autologus cell therapies using their T-Cell Antigen Coupler Platform (TAC). During this insightful discussion Paul talks about how he started in the industry, running a biotech company in today's environment, and what sets Triumvira's T-Cell therapy apart from the rest! Don't miss it!Show support for show https://www.buymeacoffee.com/biotechiqCheck out the books recommended by Paul:CEO Excellence - https://amzn.to/3OGjI3GThe Emperor of All Maladies - https://amzn.to/3IDyZ1lSupport the showCheck me out on LinkedIn https://www.linkedin.com/in/ammonr/